Insider plans Form 144 sale of 500 shares

A Form 144 notice reports a planned insider sale of 500 common shares of the issuer’s stock.

Rhea-AI Filing Summary

A Form 144 notice reports a planned insider sale of 500 common shares of the issuer’s stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on or about January 9, 2026 on the NASDAQ, with an indicated aggregate market value of $13,850.00. The filing notes that there were 342,395,697 common shares outstanding when this notice was prepared.

The 500 shares to be sold were acquired on January 9, 2026 by exercising stock options granted by the issuer, with the purchase price paid in cash. Over the prior three months, the same account carried out Rule 10b5-1 plan sales labeled for Adam Frankel, including 4,382 common shares sold on January 8, 2026 for $119,571.20 and 6,760 shares sold on December 8, 2025 for $161,174.62.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CHYM Form 144 filing disclose?

The Form 144 filing discloses a proposed sale of 500 common shares of the issuer’s stock, to be sold through Morgan Stanley Smith Barney LLC on or about January 9, 2026 on the NASDAQ, with an aggregate market value of $13,850.00.

How were the CHYM shares being sold under Form 144 acquired?

The 500 common shares covered by the notice were acquired on January 9, 2026 through an exercise of stock options from the issuer, with the purchase price paid in cash.

What does the Form 144 say about CHYM shares outstanding?

The Form 144 states that there were 342,395,697 common shares outstanding for the issuer at the time the notice was prepared, providing context for the size of the planned 500-share sale.

What recent 10b5-1 plan sales related to CHYM are disclosed?

The filing lists Rule 10b5-1 sales labeled for Adam Frankel over the prior three months, including 4,382 common shares sold on January 8, 2026 for $119,571.20 and 6,760 common shares sold on December 8, 2025 for $161,174.62, along with additional smaller trades.

Which broker is handling the CHYM Form 144 sale?

The proposed sale of 500 common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 05:06 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001241526
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chime Financial, Inc.
SEC File Number	001-42693
Address of Issuer	101 California Street, Suite 500 San Francisco CALIFORNIA 94111
Phone	844-244-6363
Name of Person for Whose Account the Securities are To Be Sold	ADAM FRANKEL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	500	13850.00	342395697	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/09/2026	Exercise of Stock Options	Issuer			500	01/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	01/08/2026	4382	119571.20
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	12/11/2025	500	13500.00
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	12/10/2025	1000	25500.00
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	12/08/2025	6760	161174.62

144: Remarks and Signature

Remarks
Date of Notice	01/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Frankel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)